Table 4 Parameters for evaluating amastigote Leishmania tropica peritoneal macrophage susceptibility to larval-derived products

No treatment control

0

2.70 ± 0.70

3.05 ± 0.57

213.3 ± 4.70

219.6 ± 4.7

Saliva

150

2.28 ± 0.81

2.0 ± 0.62

157.3 ± 2.81

116 ± 3.5

450

2.14 ± 0.67

1.81 ± 0.75

121.9 ± 3.6

83.2 ± 3

Hemolymph

150

2.17 ± 0.80

1.86 ± 0.35

136.7 ± 2.5

93 ± 3.2

450

1.95 ± 0.25

1.58 ± 0.97

97.5 ± 4.2

53.7 ± 4.2

Positive control-Glucantime

50

2.16 ± 0.50

1.86 ± 0.40

123.1 ± 5.7

81.8 ± 4